According to McKinsey research, companies with advanced digital capabilities grow revenues twice as fast as peers and deliver 25% greater total returns to shareholders annually. According to the authors of a new e-book, "today's commercial mix should reflect the fact that people are now viewing digital channels close to 50% of the time, and, even more importantly, that those people seek real engagement in regards to their care.
This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age
. The book notes that while the world has experienced an "explosion of health-oriented digital activity," there has been a simultaneous decline in pharma growth. The authors hope that most leaders of pharmaceutical companies can find new insights and approaches in their book.
Topics (partial list)
Download the full article (PDF file) here:
- Pharma's Digital Quotient
- Out-of-Sync Pharma Marketing?
- Be More Engaging
- Think in 3D
- Test and Learn